NSE: ONESOURCE | BSE: 544292

Expensive Performer

Download real time

1822.50 -12.70 (-0.69%)

72.42% Gain from 52W Low

108.6K NSE+BSE Volume

NSE 11 May, 2026 12:39 PM (IST)

20,893.6

Market Cap

High in industry

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for OneSource Specialty Pharma is on 13 May 2026 for the purpose of Audited Results See details

OneSource Specialty Pharma Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ONESOURCE, BSE:544292 OneSource Specialty Pharma Ltd.

Search Inside the pdf :

OneSource Specialty Pharma Ltd.

13 Nov 2025

1822.50

-0.69%

GLP-1 story delayed not derailed

Buy: OneSource Specialty Pharma...

ICICI Securities Limited

Delay in generic semaglutide approvals from Canadian regulator may shift the launch timeline by a quarter; however, with a few customers securing the approval in India and approvals in Brazil and Saudi Arabia expected to flow in, OneSource’s management remains confident of the upcoming opportunity, and hence, maintains FY28 guidance for its base business.

Promoters pledged 19.86% of shares in last quarter. Total pledge stands at 38.38% of promoter holdings

RESEARCH REPORTS

Buy SEE REPORTS >

pdf